Author name: Leonardo Arias

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being bent.”

The skilled nursing operator filed for bankruptcy in July, a “predictable” outcome after years of financial mismanagement from Genesis’ private equity investors, according to the Private Equity Stakeholder Project.

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott Investment Management.

The small molecule, vatiquinone, had already flunked a Phase III trial, but the company pushed ahead with an approval bid anyway.

A new study in JAMA contradicts a series of statements made by HHS Secretary Robert F. Kennedy Jr. that paint vaccine advisory committees at the CDC and FDA as hopelessly corrupt.

The average wage of chief executives rose by 27.5% from 2009 to 2023, while the average pay for all hospital employees rose 9.8%, according to research in Health Affairs.

Viking Therapeutics’ VK2735 achieves a 10.9% placebo-adjusted weight loss at 13 weeks, but a less than ideal safety profile marred the results.

Adaptive and Genentech first partnered in 2018 to advance T cell receptor-based therapies for cancer.

The FDA has postponed its decision date for Regenxbio’s Hunter syndrome gene therapy to review additional longer-term clinical data for the asset.

While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured investors it has the manufacturing capacity to roll out oral semaglutide without restrictions on supply.